Rakesh Reddy is an experienced scientist specializing in analytical development within the field of cell and gene therapy, currently employed at Immuneel Therapeutics Private Limited since June 2022. Previously, Rakesh contributed to vaccine development at Bharat Biotech International Limited, focusing on the immunogenicity of COVID-19 vaccines, where analytical methods were developed to assess T cell responses. Prior research experience includes a fellowship at the University of Maryland School of Medicine, exploring targeted delivery systems for treating autoimmune conditions, and a role at CSIR-Indian Institute of Chemical Technology, working on gold nanoparticles for DNA vaccination. Rakesh holds a Master's degree in Organic Chemistry from Osmania University.